|
|
Blood, Vol. 103, Issue 1, 325-332, January 1, 2004
Table 1.. Clinical features of patients
|
Patient
|
Age/sex
|
Diagnosis
|
Neutrophils, 103/mm3
|
Reticulocytes, 103/mm3
|
Platelets, 103/mm3
|
| 1 |
22/F |
MAA |
0.903 |
31.3 |
65 |
| 2 |
9/F |
SAA |
0.803 |
58.1 |
111 |
| 3 |
16/M |
SAA |
0.152 |
22.7 |
5 |
| 4 |
23/M |
SAA |
0.296 |
31.9 |
36 |
| 5 |
30/M |
SAA |
0.041 |
9.3 |
25 |
| 6 |
26/M |
MAA |
0.802 |
29.2 |
21 |
| 7 |
69/M |
SAA |
0.390 |
17.2 |
54 |
| 8 |
45/F |
SAA |
1.116 |
15.8 |
13 |
| 9 |
25/F |
MAA |
2.550 |
83.8 |
136 |
| 10 |
66/M |
MAA |
1.341 |
72.7 |
51 |
| 11 |
22/M |
MAA |
0.788 |
55.0 |
48 |
| 12 |
42/M |
SAA |
0.802 |
25.0 |
22 |
| 13 |
22/F |
SAA |
0.903 |
31.3 |
49 |
| 14 |
17/F |
SAA |
0.058 |
3.1 |
58 |
| 15 |
21/M |
SAA |
0.885 |
72.9 |
8 |
| 16 |
50/M |
SAA |
0.315 |
16.6 |
8 |
| 17 |
33/F |
MAA |
2.486 |
46.3 |
239 |
| 18 |
68/M |
SAA |
0.461 |
16.2 |
24 |
| 19 |
28/F |
SAA |
0.620 |
22.9 |
44 |
| 20 |
19/M |
SAA |
NA |
41.3 |
27 |
| 21 |
30/M |
SAA |
0.014 |
2.7 |
21 |
| 22 |
51/M |
SAA |
0.024 |
2.6 |
1 |
| 23 |
11/F |
SAA |
0.431 |
50.2 |
13 |
| 24 |
28/F |
SAA |
1.131 |
15.5 |
8 |
| 25 |
55/F |
SAA |
0.650 |
7.1 |
53 |
| 26 |
40/F |
MAA |
3.050 |
72.3 |
23 |
| 27 |
37/M |
MAA |
2.010 |
39.3 |
35 |
| 28 |
74/M |
SAA |
NA |
31.4 |
8 |
| 29 |
48/M |
SAA |
0.180 |
8.0 |
13 |
| 30 |
65/M |
SAA |
0.790 |
21.1 |
25 |
| 31 |
27/M |
SAA |
0.050 |
3.5 |
34 |
| 32 |
82/M |
SAA |
0.220 |
18.2 |
25 |
| 33 |
17/F |
MAA |
1.930 |
35.3 |
57 |
| 34 |
66/M |
SAA |
3.350 |
0.7 |
38 |
| 35 |
57/M |
MAA |
1.190 |
56.4 |
124 |
36
|
56/F
|
SAA
|
0.090
|
50.2
|
84
|
|
All patients received new diagnoses, but had not been treated. MAA indicates moderate AA; SAA, severe AA; NA, not available.
|
|
